We bridge the gap between families living with rare diseases and the insights that drive better care.
Why it matters
Over 300 million people worldwide are living with a rare disease.
Many families struggle to track symptoms, manage treatments, and access proper care.
AI-driven insights can improve patient outcomes by making data more accessible and actionable.
Rare diseases impact millions, yet reliable tools and support are often lacking. We’re changing that by building AI-driven apps that simplify disease management, empower families, and help healthcare professionals deliver better care.
We develop intelligent, user-friendly apps tailored for conditions like epilepsy, Lennox-Gastaut Syndrome, and Dravet Syndrome.
Our technology transforms patient-reported data into actionable insights, helping caregivers, doctors, and researchers make informed decisions.
We work with pharmaceutical leaders to enhance patient engagement, improve adherence, and advance rare disease research through real-world data.
